M&T Bank Corp Verrica Pharmaceuticals Inc. Transaction History
M&T Bank Corp
- $28.9 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding VRCA
# of Institutions
6Shares Held
1.14MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Fin Trust Capital Advisors, LLC10KShares$79,5000.01% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ568Shares$4,5150.0% of portfolio
-
Cwm, LLC28Shares$2220.0% of portfolio
-
Carmichael Hill & Associates, Inc.21Shares$1660.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...